These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target. Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156 [TBL] [Abstract][Full Text] [Related]
43. Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog. Nagatsugi F; Sasaki S; Miller PS; Seidman MM Nucleic Acids Res; 2003 Mar; 31(6):e31. PubMed ID: 12626730 [TBL] [Abstract][Full Text] [Related]
44. Recruitment of transcription factors to the target site by triplex-forming oligonucleotides. Svinarchuk F; Nagibneva I; Cherny D; Ait-Si-Ali S; Pritchard LL; Robin P; Malvy C; Harel-Bellan A; Chern D Nucleic Acids Res; 1997 Sep; 25(17):3459-64. PubMed ID: 9254704 [TBL] [Abstract][Full Text] [Related]
46. Stable and Selective Antiparallel Type Triplex DNA Formation by Targeting a GC Base Pair with the TFO Containing One N Taniguchi Y; Miyazaki M; Matsueda N; Wang L; Okamura H; Sasaki S Chem Pharm Bull (Tokyo); 2018; 66(6):624-631. PubMed ID: 29863064 [TBL] [Abstract][Full Text] [Related]
47. Measurement of histone mRNA transcript abundance in Xenopus oocytes by a quantitative primer extension assay. Brashears-Macatee S; Hinkley C; Perry M Mol Reprod Dev; 1990 Jan; 25(1):22-7. PubMed ID: 2393580 [TBL] [Abstract][Full Text] [Related]
48. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus. Maldonado R; Filarsky M; Grummt I; Längst G RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118 [TBL] [Abstract][Full Text] [Related]
49. Triple helix-mediated inhibition of gene expression is increased by PUVA. Besch R; Marschall C; Schuh T; Giovannangeli C; Kammerbauer C; Degitz K J Invest Dermatol; 2004 May; 122(5):1114-20. PubMed ID: 15140212 [TBL] [Abstract][Full Text] [Related]
50. In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. Ing NH; Beekman JM; Kessler DJ; Murphy M; Jayaraman K; Zendegui JG; Hogan ME; O'Malley BW; Tsai MJ Nucleic Acids Res; 1993 Jun; 21(12):2789-96. PubMed ID: 8332487 [TBL] [Abstract][Full Text] [Related]
51. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Hagenbuch B; Scharschmidt BF; Meier PJ Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):901-4. PubMed ID: 8670169 [TBL] [Abstract][Full Text] [Related]
52. Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Jespersen T; Grunnet M; Angelo K; Klaerke DA; Olesen SP Biotechniques; 2002 Mar; 32(3):536-8, 540. PubMed ID: 11911656 [TBL] [Abstract][Full Text] [Related]
53. Kinetic study of the binding of triplex-forming oligonucleotides containing partial cationic modifications to double-stranded DNA. Hari Y; Ijitsu S; Akabane-Nakata M; Yoshida T; Obika S Bioorg Med Chem Lett; 2014 Jul; 24(14):3046-9. PubMed ID: 24865415 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of DNA replication in cell-free extracts of Xenopus laevis eggs by extracts of Xenopus laevis oocytes. Zhao J; Benbow RM Dev Biol; 1994 Jul; 164(1):52-62. PubMed ID: 8026636 [TBL] [Abstract][Full Text] [Related]
55. Interference with MCP-1 gene expression by vector generated triple helix-forming RNA oligonucleotides. Kautz K; Schwarz M; Radeke HH Cell Mol Life Sci; 2005 Feb; 62(3):362-76. PubMed ID: 15723171 [TBL] [Abstract][Full Text] [Related]
56. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells. Kim HG; Miller DM Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417 [TBL] [Abstract][Full Text] [Related]
57. A triple-helix forming oligonucleotide targeting genomic DNA fails to induce mutation. Reshat R; Priestley CC; Gooderham NJ Mutagenesis; 2012 Nov; 27(6):713-9. PubMed ID: 22914677 [TBL] [Abstract][Full Text] [Related]
58. Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids. Ziemba AJ; Zhilina ZV; Krotova-Khan Y; Stankova L; Ebbinghaus SW Oligonucleotides; 2005; 15(1):36-50. PubMed ID: 15788899 [TBL] [Abstract][Full Text] [Related]